9th Circ. Decision Could Be A Bitter Pill For Pharma Cos.

Insights

Publication | 09.09.25

PE Firms Leap Into MSO 'Frontier' For Slice Of Legal Industry

• Publication | 09.03.25

  Antitrust Risks in Responding To Tariffs

• Publication | 08.29.25

  Design Versus Performance Specifications In Construction Projects

• Publication | 08.27.25

  False Claims Act Qui Tam Actions Won’t Doom Public Universities